Hawke's Bay COVID-19 Vaccine Information

What's on where?

You can book an appointment online at www.bookmyvaccine.nz or call 0800 28 29 26. Walk-in and drive-in vaccinations are also available at many sites. Find a full list of clinic locations and hours including mobile vans, pop-ups, GP and Pharmacy vaccination clinics at www.healthpoint.co.nz.

Local vaccination rates:

98% of the eligible population have had 1 dose of a vaccine. 96% have had two doses and 92% have had a booster.*

*More information about the Hawke's Bay vaccination rates can be found here 


COVID-19 vaccinations for children:

Parents and caregivers can protect their children aged 5 to 11 against COVID-19 with the child version of the Pfizer vaccine.

As we have seen to date, the virus can be unpredictable. While COVID-19 generally has milder effects in children, with symptoms similar to a cold, some children become severely ill and require hospitalisation.

Like we have seen with adults, if your child is infected with COVID-19 they may transmit the virus to other people. Immunising 5 to 11-year-olds helps protect whānau members whose health makes them more vulnerable to COVID-19.

More information about vaccinations for 5-11 year olds can be found here.

COVID-19 vaccine to be available February 2023 for immunocompromised and high-risk under 5 year olds

  • Ministers have approved use of the paediatric Pfizer COVID-19 vaccine for children aged six months to four years who are at higher risk of severe disease if they were to catch COVID-19.
  • Eligibility is limited to children who are severely immunocompromised, or who have complex and/or multiple health conditions which increase the risk of severe disease from COVID-19 (following the Starship Child Health table of underlying comorbidities).
  • The vaccine is anticipated to be available in February 2023. A further announcement will be made in early 2023 when timing of vaccine delivery is confirmed. When timing is confirmed, bookings for this vaccine will be available by calling Healthline on 0800 28 29 26 or visiting www.BookMyVaccine.nz
  • The vaccine for this age group is an adapted version of the vaccine used for five to 11 olds.
  • The approval is for three doses of the adapted paediatric Pfizer COVID-19 vaccine, with the second dose given three weeks after the first dose, followed by a third dose given at least 8 weeks after the second dose.
  • The COVID-19 Technical Advisory Group does not currently recommend vaccination for children aged 6 months to 4 years who are not in these risk categories for severe COVID-19.  These children have a very low likelihood of severe illness from COVID-19.


Third Primary dose for 5-11 year olds who are severely immuno-compromised children.

  • Severely immunocompromised children aged 5 to 11 can receive a third primary dose of the Pfizer COVID-19 vaccine.
  • There are specific criteria for which children qualify for a third primary dose.  
  • The third primary dose must be prescribed by an authorised prescriber such as a medical practitioner or nurse practitioner. Appointments to discuss whether your child is eligible for a third primary dose are free.
  • Scripts for a third primary dose can be taken to any vaccination site. 
  • The third primary dose should be given 8 weeks after the second dose but may be given after 4 weeks depending on current or planned immunosuppressive therapies. 
  • People with known severe immunocompromise from disease or its treatment are encouraged to contact their GP or treating health professional to discuss the timing, prescription and administration of this additional dose of vaccine. 
  • The third primary dose is optional but recommended by the COVID-19 Vaccine Technical Advisory Group.
  • A third primary dose is also being offered to severely immunocompromised children in this age group overseas, including in Australia, the United States, Canada, and the United Kingdom.


In addition:

  • Individuals who are severely immunocompromised are at higher risk of severe outcomes from COVID-19, and might not produce a sufficiently strong immune response after two doses of the Pfizer COVID-19 vaccine. A third primary dose offers extra protection for the individual, and may help reduce the likelihood of them transmitting the virus to others.  
  • A prescription must be provided by a GP, nurse practitioner, or other treating health professional before people who are severely immunocompromised can be given a third primary dose. 
  • It’s recommended that parents or guardians of a severely immunocompromised child schedule an appointment with their usual health care professional who has access to the child’s medical records. This will help confirm whether the child qualifies for a third primary dose.  
  • Your child might be able to receive the third primary dose at the same time as their consultation – check with your prescriber to see if they offer the child Pfizer COVID-19 vaccine. 
  • The third primary dose should be given 8 weeks after the second dose but may be given after 4 weeks depending on current or planned immunosuppressive therapies. Talk to your child’s GP or specialist for advice on timing.
  • It is strongly encouraged that all household contacts of someone who is severely immunocompromised (regardless of their age) are up-to-date with their recommended COVID-19 vaccines to help provide indirect protection. 


Pfizer booster vaccinations:

People aged 18 and over can get a booster vaccination 3 months after their second dose. People 16 and 17 can get a booster 6 months after their second dose. Booster vaccinations are available at all participating vaccination clinics. (See www.healthpoint.co.nz

You can go to a walk-in clinic or book an appointment to get a booster online through www.bookmyvaccine.nz

We encourage anyone who had their second vaccination more than 3 months ago to get their booster as soon as possible.

Booster vaccinations are free for anyone in New Zealand aged 18 or older. For more information about COVID-19 booster vaccinations click here.


Second boosters

A second booster is recommended for those at increased risk of severe illness from COVID-19 – a minimum of 6 months after a first booster. 

First and second boosters help to reduce the chance of more serious illness and hospitalisation, so we strongly recommend people book in for all vaccines they are eligible for.

For those who are not considered at risk of severe illness from COVID-19, a two-dose primary course and a first booster dose provides very good protection against severe illness from COVID-19 at this time. Find out more here



Information about vaccines

Pfizer COVID-19 vaccine

The Pfizer vaccine (Comirnaty) is an mRNA vaccine that contains the genetic code for an important part of the SARS-CoV-2 (COVID-19) virus called the ‘spike protein’. Spike proteins are the little projections on the surface of the virus. Pfizer is the main vaccine used in NZ. 

mRNA vaccines do not contain any of the virus that causes COVID-19, or any other live, dead or deactivated viruses.

The COVID-19 vaccine is given as an injection into the muscle of your upper arm. You’ll need two doses, at least 3 weeks apart. Booster vaccinations are also available 3 months following your second dose for 18+ (6 months for 16-17 year olds).

Read more about the Pfizer vaccine here.

Information for severely immunocompromised people, including how to access a third primary dose of the COVID-19 vaccine

A third primary dose of the COVID-19 vaccine has been recommended for severely immunocompromised individuals aged 12 and older. Individuals who are severely immunocompromised are at a higher risk of severe outcomes from COVID-19 and might not produce a sufficiently strong immune response after two doses of the Pfizer COVID-19 vaccine. A third primary dose may be beneficial and can be administered at least eight weeks after the second dose. For more information please visit https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-vaccines/covid-19-vaccine-health-advice/covid-19-vaccine-severely-immunocompromised-people  

AstraZeneca COVID-19 vaccine

The AstraZeneca COVID-19 vaccine is no longer available in NZ.

Novavax COVID-19 vaccine

The Novavax COVID-19 vaccine (Nuvaxovid) has now been approved to be used as a primary vaccination course for people aged 12 and older in Aotearoa. Novavax is only available as a booster for those aged 18 years and above. 

Novavax is only available at select vaccination sites (see www.healthpoint.co.nz)

The primary course of Novavax is two doses three weeks apart. Read more here. 


Booking information

How to make (or manage) a booking:

Vaccinations are also available at some other general practices, local pharmacies, churches and marae, please see www.healthpoint.co.nz.

He pātai?

If you have any queries about the COVID-19 vaccine visit www.covid19.govt.nz.